IM
ImageneBio Inc (IMA)
NASDAQ·Healthcare·Biotechnology
$5.80
-0.60%
Mkt Cap $66.20M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | — | — | — | -$1.45 | -$0.62 | +57.24% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$1.47 | -$2.91 | -97.96% | — | — |
| Q3 2025 Jul 24, 2025 | — | — | — | -$0.14 | -$0.06 | +57.14% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.21 | -$0.18 | +14.29% | — | — |
| Q1 2025 Mar 6, 2025 | $875.00K | — | — | -$0.19 | -$0.18 | +5.26% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.27 | -$0.19 | +29.63% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.31 | -$0.27 | +12.90% | — | — |
| Q2 2024 May 13, 2024 | $1.75M | — | — | -$0.40 | -$0.28 | +30.00% | — | — |
| Q1 2024 Mar 12, 2024 | $3.14M | $659.00K | -79.01% | -$0.41 | -$0.41 | +0.00% | — | — |
| Q4 2023 Nov 9, 2023 | $2.81M | $1.19M | -57.83% | -$0.44 | -$0.40 | +9.09% | — | — |
| Q3 2023 Aug 10, 2023 | $3.08M | $2.00M | -34.94% | -$0.48 | -$0.44 | +8.33% | — | — |
| Q2 2023 May 15, 2023 | $4.61M | $5.31M | +15.25% | -$0.46 | -$0.39 | +15.22% | — | — |
| Q1 2023 Mar 14, 2023 | $6.02M | $5.45M | -9.47% | -$0.53 | -$0.39 | +26.42% | — | — |
| Q4 2022 Nov 7, 2022 | $4.32M | $6.40M | +48.06% | -$0.50 | -$0.48 | +4.00% | — | — |
| Q3 2022 Aug 11, 2022 | $3.87M | $382.00K | -90.14% | -$0.48 | -$0.57 | -18.75% | — | — |
| Q2 2022 May 12, 2022 | $4.57M | $3.38M | -25.93% | -$0.42 | -$0.47 | -11.90% | — | — |
| Q1 2022 Mar 17, 2022 | $4.79M | $20.22M | +322.42% | -$0.51 | $0.07 | +113.73% | — | — |
| Q4 2021 Nov 10, 2021 | $8.63M | $3.75M | -56.61% | -$0.41 | -$0.40 | +2.44% | — | — |
| Q3 2021 Aug 12, 2021 | $3.93M | $3.55M | -9.69% | -$0.32 | -$0.35 | -9.37% | — | — |
| Q2 2021 May 13, 2021 | $5.33M | $3.47M | -34.87% | -$0.68 | -$2.52 | -270.59% | — | — |